Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hauser

Showing results (201-210 of 419) with videos related to

Pageof 42
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2021
Specific hypomethylation programs underpin B cell activation in early multiple sclerosisQin Ma, Stacy J Caillier, Shaun Muzic, et al.
Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.
Lancet (London, England)|November 4, 2011
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialLudwig Kappos, David Li, Peter A Calabresi, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
Human Molecular Genetics|October 5, 2015
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactomeAlessandro Didonna, Noriko Isobe, Stacy J Caillier, et al.
Frontiers in Physiology|July 14, 2022
Effect of Plyometric Jump Training on Skeletal Muscle Hypertrophy in Healthy Individuals: A Systematic Review With Multilevel Meta-AnalysisF Arntz, B Mkaouer, A Markov, et al.
The Neurologist|June 14, 2003
Approved and future pharmacotherapy for multiple sclerosisOlaf Stüve, Bruce C Cree, Hans-Christian von Büdingen, et al.
JAMA Neurology|June 9, 2020
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsLudwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, et al.
The Journal of Experimental Medicine|June 26, 2013
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunityUlf Schulze-Topphoff, Simona Casazza, Michel Varrin-Doyer, et al.
BMC Medical Genetics|July 28, 2015
Genetic contribution to multiple sclerosis risk among Ashkenazi JewsPouya Khankhanian, Takuya Matsushita, Lohith Madireddy, et al.
Pageof 42

Showing results (201-210 of 419) with videos related to

Sort By:
Pageof 42
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2021
Specific hypomethylation programs underpin B cell activation in early multiple sclerosisQin Ma, Stacy J Caillier, Shaun Muzic, et al.
Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.
Lancet (London, England)|November 4, 2011
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialLudwig Kappos, David Li, Peter A Calabresi, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
Human Molecular Genetics|October 5, 2015
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactomeAlessandro Didonna, Noriko Isobe, Stacy J Caillier, et al.
Frontiers in Physiology|July 14, 2022
Effect of Plyometric Jump Training on Skeletal Muscle Hypertrophy in Healthy Individuals: A Systematic Review With Multilevel Meta-AnalysisF Arntz, B Mkaouer, A Markov, et al.
The Neurologist|June 14, 2003
Approved and future pharmacotherapy for multiple sclerosisOlaf Stüve, Bruce C Cree, Hans-Christian von Büdingen, et al.
JAMA Neurology|June 9, 2020
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsLudwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, et al.
The Journal of Experimental Medicine|June 26, 2013
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunityUlf Schulze-Topphoff, Simona Casazza, Michel Varrin-Doyer, et al.
BMC Medical Genetics|July 28, 2015
Genetic contribution to multiple sclerosis risk among Ashkenazi JewsPouya Khankhanian, Takuya Matsushita, Lohith Madireddy, et al.
Pageof 42